- Home
- JDZG vs PMCB Comparison
JDZG vs PMCB Comparison
Compare JDZG & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- PMCB
- Stock Information
- Founded
- JDZG 2020
- PMCB 1996
- Country
- JDZG China
- PMCB United States
- Employees
- JDZG N/A
- PMCB N/A
- Industry
- JDZG Other Consumer Services
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JDZG Real Estate
- PMCB Health Care
- Exchange
- JDZG Nasdaq
- PMCB Nasdaq
- Market Cap
- JDZG 7.2M
- PMCB 7.3M
- IPO Year
- JDZG 2024
- PMCB N/A
- Fundamental
- Price
- JDZG $2.44
- PMCB $1.15
- Analyst Decision
- JDZG
- PMCB
- Analyst Count
- JDZG 0
- PMCB 0
- Target Price
- JDZG N/A
- PMCB N/A
- AVG Volume (30 Days)
- JDZG 106.9K
- PMCB 10.2K
- Earning Date
- JDZG 07-07-2025
- PMCB 08-12-2025
- Dividend Yield
- JDZG N/A
- PMCB N/A
- EPS Growth
- JDZG N/A
- PMCB N/A
- EPS
- JDZG 0.25
- PMCB 1.29
- Revenue
- JDZG $2,567,741.00
- PMCB N/A
- Revenue This Year
- JDZG N/A
- PMCB N/A
- Revenue Next Year
- JDZG N/A
- PMCB N/A
- P/E Ratio
- JDZG $10.05
- PMCB $0.84
- Revenue Growth
- JDZG 20.36
- PMCB N/A
- 52 Week Low
- JDZG $1.61
- PMCB $1.00
- 52 Week High
- JDZG $21.28
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- PMCB 54.97
- Support Level
- JDZG N/A
- PMCB $1.00
- Resistance Level
- JDZG N/A
- PMCB $1.12
- Average True Range (ATR)
- JDZG 0.00
- PMCB 0.05
- MACD
- JDZG 0.00
- PMCB 0.01
- Stochastic Oscillator
- JDZG 0.00
- PMCB 79.55
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.